Our Pricing

Antiviral Treatment: Advantages and Disadvantages

Understanding antiviral treatment weight loss UK options requires weighing clinical benefits against potential drawbacks. At Cured Pharmacy, our UK-registered clinical team has guided thousands of patients through prescription weight loss treatments, from GLP-1 receptor agonists like Mounjaro and Wegovy to fat absorption inhibitors like Orlistat. This comprehensive guide examines the advantages and disadvantages of each treatment class to help you make an informed decision.

Advantages of GLP-1 Receptor Agonist Weight Loss Treatments

GLP-1 receptor agonists represent the most significant advancement in obesity medicine in decades, offering weight reduction outcomes previously achievable only through bariatric surgery [1]. These injectable medications—including tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda)—work by mimicking natural hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity.

The primary advantage lies in their clinical efficacy. In the SURPASS-3 trial, patients using tirzepatide achieved an average 22.5% body weight reduction over 72 weeks at the highest dose [1]. Similarly, the STEP trials demonstrated that semaglutide produced average weight loss of 14.9% over 68 weeks [2]. These results far exceed older weight loss medications and represent clinically meaningful improvements in cardiovascular risk factors.

Beyond weight reduction, GLP-1 treatments offer cardiovascular benefits documented in multiple trials. Patients experience improvements in blood pressure, lipid profiles, and glycaemic control—even those without diabetes [3]. The once-weekly injection schedule for Mounjaro and Wegovy provides convenience compared to daily medications, and many patients report reduced food cravings and improved satiety between meals.

Who Benefits Most from GLP-1 Treatments

UK prescribers typically recommend GLP-1 receptor agonists for adults with a BMI of 30 or above, or 27 or above with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. These treatments prove particularly effective for patients who have struggled with traditional diet and exercise programmes or who require significant weight reduction to improve metabolic health. At Cured Pharmacy, Mounjaro starts from £135.00, with transparent pricing displayed before your free consultation with a UK prescriber.

Disadvantages and Side Effects of Injectable Weight Loss Medications

Despite their efficacy, GLP-1 receptor agonists carry notable disadvantages that patients must consider. Gastrointestinal side effects affect the majority of users, particularly during dose escalation. Nausea occurs in 40-50% of patients, with additional reports of vomiting, diarrhoea, constipation, and abdominal discomfort [1][2]. While these symptoms typically diminish over 4-8 weeks, they can significantly impact quality of life during the initial treatment phase.

The injection requirement presents a barrier for needle-phobic patients, though most find the subcutaneous administration technique straightforward after initial guidance. More concerning are the contraindications: GLP-1 treatments are unsuitable for patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [4]. Pregnant or breastfeeding women cannot use these medications, and they require careful consideration in patients with severe gastrointestinal disease or pancreatitis history.

Cost represents another significant disadvantage. Prescription weight loss injections require ongoing monthly expenditure, and treatment typically continues for 12-24 months or longer to maintain results. Patients who discontinue treatment often experience weight regain, necessitating long-term commitment. Additionally, all GLP-1 medications require clinical assessment by a UK prescriber and are not suitable for everyone.

Advantages of Oral Weight Loss Medications Like Orlistat

Orlistat offers distinct advantages as the UK's most established oral weight loss medication, available in prescription strength (120mg) and over-the-counter formulations (60mg). Unlike GLP-1 treatments that work centrally on appetite, Orlistat inhibits pancreatic lipase enzymes, preventing approximately 30% of dietary fat absorption [5]. This local mechanism means the medication doesn't enter systemic circulation, reducing the risk of widespread side effects.

The primary advantage of Orlistat lies in its safety profile and accessibility. With over two decades of clinical use, its side effect spectrum is well-characterised and generally manageable. Patients can start treatment more affordably, with options available from £135.00 for lower-dose formulations. The oral administration eliminates injection concerns, and the medication can be taken only when needed—skipping doses on low-fat meal days without compromising efficacy.

Orlistat works best as part of a structured weight management programme, teaching patients to moderate fat intake naturally. This educational component can foster sustainable dietary changes. The medication is suitable for long-term use without the tolerance issues seen with older appetite suppressants, and it carries approval for patients as young as 12 years old in certain circumstances [5].

Clinical Outcomes with Fat Absorption Inhibitors

In clinical trials, Orlistat 120mg combined with reduced-calorie diet produced average weight loss of 5-10% over 12 months—modest compared to GLP-1 treatments but clinically meaningful for cardiovascular risk reduction [5]. Patients also demonstrated improvements in cholesterol levels and blood pressure. The key lies in realistic expectations: Orlistat supports gradual, sustainable weight loss rather than rapid reduction.

Disadvantages of Orlistat and Fat Absorption Inhibitors

The primary disadvantage of Orlistat stems directly from its mechanism of action. Unabsorbed dietary fat passes through the digestive system, causing gastrointestinal side effects in most users. Oily spotting, flatulence with discharge, faecal urgency, and oily stools occur frequently, particularly when patients consume high-fat meals [5]. These effects, while not medically dangerous, can be socially embarrassing and impact quality of life.

Orlistat's efficacy depends entirely on dietary fat intake, making it less effective for patients who consume low-fat diets or struggle with carbohydrate-driven weight gain. The medication requires three-times-daily dosing with meals, demanding more frequent administration than once-weekly injections. Additionally, Orlistat can interfere with absorption of fat-soluble vitamins (A, D, E, K), necessitating supplementation taken at least two hours apart from the medication [5].

Weight loss outcomes with Orlistat typically fall below those achieved with GLP-1 receptor agonists, making it less suitable for patients requiring substantial weight reduction. The medication also demands significant behavioural commitment—patients must consistently follow a reduced-calorie, lower-fat diet to see results and minimise side effects. For these reasons, UK prescribers often position Orlistat as a first-line option for patients with lower BMI or as an alternative when injectable treatments are unsuitable.

Comparing Treatment Options: Which Disadvantages Matter Most

Selecting the right weight loss treatment requires balancing clinical efficacy against individual tolerance for specific disadvantages. Patients prioritising maximum weight reduction and willing to manage initial nausea typically favour GLP-1 receptor agonists like Mounjaro or Wegovy. Those with needle phobia, budget constraints, or preference for oral medication may find Orlistat-based treatments more acceptable despite modest efficacy.

Your medical history significantly influences treatment suitability. Patients with type 2 diabetes benefit from GLP-1 treatments' dual effects on weight and glycaemic control [3]. Those with gallbladder disease or malabsorption disorders should avoid Orlistat. Cardiovascular risk factors may tip the balance toward GLP-1 treatments given their documented heart health benefits beyond weight loss [3].

At Cured Pharmacy, our UK-registered prescribers assess your complete medical profile during the free online consultation, which takes under three minutes. We stock the full range of licensed weight loss treatments, from Mounjaro and Wegovy injections to Orlistat and Xenical capsules, ensuring you receive the most appropriate medication rather than a one-size-fits-all approach. All treatments require clinical approval and are dispensed only when safe and suitable for your individual circumstances.

Long-Term Considerations and Treatment Duration

Weight loss medications work best as part of comprehensive lifestyle modification, not as standalone solutions. Clinical trials demonstrating impressive outcomes all included dietary counselling and physical activity recommendations [1][2]. Most patients require 12-24 months of treatment to achieve target weight loss, with many continuing longer for weight maintenance. Discuss realistic timelines and commitment expectations with your prescriber before starting treatment.

Making an Informed Decision About Weight Loss Treatment

The advantages and disadvantages of weight loss treatments extend beyond simple efficacy comparisons. Consider your lifestyle, medical history, budget, tolerance for side effects, and weight loss goals when evaluating options. GLP-1 receptor agonists offer superior weight reduction but require injection comfort and higher investment. Orlistat provides accessible oral treatment with local side effects and modest outcomes.

Transparency in pricing helps inform your decision. At Cured Pharmacy, you'll see exact costs before consultation—no hidden fees or surprise charges. We guarantee the lowest prices in the UK on genuine, licensed medications dispensed by our GPhC-registered pharmacy (9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073). Every prescription treatment includes free delivery in discreet packaging and ongoing support from our clinical team.

Ready to explore which weight loss treatment suits your needs? Start your free online consultation today. Our UK prescribers will assess your medical history, discuss advantages and disadvantages of suitable options, and recommend the most appropriate treatment for your individual circumstances. With transparent pricing, genuine medications, and expert clinical guidance, Cured Pharmacy makes evidence-based weight management accessible and straightforward.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875
5. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications alongside medication use.